Guiding principles and checklist for population-based quality metrics

Clinical Journal of the American Society of Nephrology

Volumn 9, Issue 6, 2014, Pages 1124-1131

  Krishnan, Mahesh ^a   Brunelli, Steven M ^a   Maddux, Franklin W ^b   Parker, Thomas F ^d   Johnson, Douglas ^e   Nissenson, Allen R ^a   Collins, Allan ^f   Lacson, Eduardo ^c  

^a DaVita HealthCare Partners   (United States)

^b Medical and Scientific Affairs   (United States)

^c Clinical Science Epidemiology and Research Fresenius Medical Care North America ^*  (United States)

^d Renal Ventures Management   (United States)

^e Dialysis Clinic Inc   (United States)

^f MINNEAPOLIS MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ARTICLE; CLINICAL ASSESSMENT; CLINICAL PERFORMANCE MEASURE; END STAGE RENAL DISEASE; HEALTH CARE; HEALTH CARE DELIVERY; HEALTH CARE FACILITY; HEALTH CARE QUALITY; HEALTH INSURANCE; HEALTH SERVICE; HOSPITAL COST; HUMAN; METRIC SYSTEM; NATIONAL QUALITY FORUM; PATIENT CARE; POPULATION RESEARCH; RANDOMIZED CONTROLLED TRIAL (TOPIC); RELIABILITY; STATISTICAL PARAMETERS; CHECKLIST; EVIDENCE BASED MEDICINE; KIDNEY FAILURE, CHRONIC; PROSPECTIVE PAYMENT; RENAL REPLACEMENT THERAPY; REPRODUCIBILITY; STANDARDS; TOTAL QUALITY MANAGEMENT; TREATMENT OUTCOME; UNITED STATES; VALIDATION STUDY;

CHECKLIST; EVIDENCE-BASED MEDICINE; HUMANS; KIDNEY FAILURE, CHRONIC; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PROSPECTIVE PAYMENT SYSTEM; QUALITY IMPROVEMENT; QUALITY INDICATORS, HEALTH CARE; RENAL DIALYSIS; REPRODUCIBILITY OF RESULTS; UNITED STATES; VALIDATION STUDIES AS TOPIC;

EID: 84923797028     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.11061013     Document Type: Article

References (14)

1. Goodrich K, Garcia E, Conway PH: A history of and a vision for CMS quality measurement programs. Jt Comm J Qual Patient Saf 38: 465–470, 2012.
2. VanLare JM, Conway PH: Value-based purchasing—national programs to move from volume to value. N Engl J Med 367: 292–295, 2012.
3. Centers for Medicare and Medicaid Services: Centers for Medicare and Medicaid Services End-Stage Renal Disease Quality Incentive Program 2016 Payment System Proposed Rule, 2013. Available at: http://www.cms.gov/Outreach-and-Education/Outreach/NPC/Downloads/2013-08-14-ProposedRule-NPC.pdf. Accessed December 9, 2013.
4. National Quality Forum: 2013 National Quality Forum Measure Evaluation Criteria, 2013. Available at: http://www.qualityforum.org/docs/measure_evaluation_criteria.aspx. Accessed December 13, 2013.
5. Krishnan M, Wilfehrt HM, Lacson E Jr.: In data we trust: The role and utility of dialysis provider databases in the policy process. Clin J Am Soc Nephrol 7: 1891–1896, 2012.
6. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Schünemann HJ; GRADEWorking Group: GRADE: An emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336: 924–926, 2008.
7. RE: CMS-1352-P: Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Bad Debt Reductions for All Medicare Providers; Proposed Rule, 2013. Available at: http://www.asn-online.org/policy/webdocs/12.8.31_submittedqipcomments.docx.pdf. Accessed September 16, 2013.
8. Parker TF 3rd, Hakim R, Nissenson AR, Krishnan M, Bond TC, Chan K, Maddux FW, Glassock R: A quality initiative. Reducing rates of hospitalizations by objectively monitoring volume removal. Nephrol News Issues 27: 30–36, 2013.
9. Centers for Medicare & Medicaid Services (CMS); HHS: Medicare program; end-stage renal disease prospective payment system, quality incentive program, and bad debt reductions for allMedicare providers. Final rule. Fed Regist 77: 67450–67531, 2012.
10. Nissenson AR: Improving outcomes for ESRD patients: Shifting the quality paradigm[published online ahead of print November 7, 2013]. Clin J Am Soc Nephrol.
11. Uhlig K, Macleod A, Craig J, Lau J, Levey AS, Levin A, Moist L, Steinberg E, Walker R, Wanner C, Lameire N, Eknoyan G: Grading evidence and recommendations for clinical practice guidelines in nephrology. A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 70: 2058–2065, 2006.
12. Wolfe RA, Hulbert-Shearon TE, Ashby VB, Mahadevan S, Port FK: Improvements in dialysis patient mortality are associated with improvements in urea reduction ratio and hematocrit, 1999 to 2002. Am J Kidney Dis 45: 127–135, 2005.
13. Lacson E Jr., Wang W, Hakim RM, Teng M, Lazarus JM: Associates of mortality and hospitalization in hemodialysis: Potentially actionable laboratory variables and vascular access. Am J Kidney Dis 53: 79–90, 2009.
14. Lacson E Jr., Wang W, Lazarus JM, Hakim RM: Hemodialysis facility-based quality-of-care indicators and facility-specific patient outcomes. Am J Kidney Dis 54: 490–497, 2009.